SRE | ||
---|---|---|
OUTLOOK RATING 1..100 | 16 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 38 | |
SMR RATING 1..100 | 100 | |
PRICE GROWTH RATING 1..100 | 49 | |
P/E GROWTH RATING 1..100 | 48 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IFGL | SRE | |
---|---|---|
RSI ODDS (%) | 2 days ago77% | 2 days ago51% |
Stochastic ODDS (%) | 2 days ago74% | 2 days ago44% |
Momentum ODDS (%) | 2 days ago77% | 2 days ago53% |
MACD ODDS (%) | 2 days ago74% | 2 days ago52% |
TrendWeek ODDS (%) | 2 days ago80% | 2 days ago52% |
TrendMonth ODDS (%) | 2 days ago79% | 2 days ago50% |
Advances ODDS (%) | 2 days ago80% | 6 days ago55% |
Declines ODDS (%) | 6 days ago83% | 22 days ago49% |
BollingerBands ODDS (%) | 5 days ago84% | 2 days ago57% |
Aroon ODDS (%) | 2 days ago81% | 2 days ago45% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MMSC | 21.11 | 0.41 | +1.98% |
First Trust Multi-Manager Sm Cp Opps ETF | |||
FELG | 38.13 | 0.74 | +1.98% |
Fidelity Enhanced Large Cap Growth ETF | |||
IBGK | 23.80 | 0.40 | +1.72% |
iShares iBonds Dec 2054 Term Trsy ETF | |||
PPH | 85.65 | 1.13 | +1.34% |
VanEck Pharmaceutical ETF | |||
BNOV | 41.94 | 0.45 | +1.08% |
Innovator US Equity Buffer ETF Nov |
A.I.dvisor indicates that over the last year, IFGL has been loosely correlated with SPG. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if IFGL jumps, then SPG could also see price increases.
Ticker / NAME | Correlation To IFGL | 1D Price Change % | ||
---|---|---|---|---|
IFGL | 100% | +1.42% | ||
SPG - IFGL | 61% Loosely correlated | +2.03% | ||
LAND - IFGL | 47% Loosely correlated | +0.22% | ||
SRE - IFGL | 39% Loosely correlated | +2.48% | ||
ALNT - IFGL | 39% Loosely correlated | +4.34% | ||
HMC - IFGL | 38% Loosely correlated | +1.21% | ||
More |